N Scott Fine insider trades: Cyclo Therapeutics (CYTH) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where N reports to the SEC
Open-market buys and sales
12 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Apr 20, 2023 | CYTH | ↑ Buy | 299,402 | $0.71 | $213K | Direct | Apr 24, 2023 (4d) |
| Feb 7, 2022 | CYTH | ↑ Buy | 10,334 | $3.58 | $37K | Direct | Feb 7, 2022 (0d) |
| Jan 19, 2022 | CYTH | ↑ Buy | 5,000 | $3.89 | $19K | Direct | Jan 19, 2022 (0d) |
| Dec 15, 2021 | CYTH | ↑ Buy | 5,000 | $3.89 | $19K | Direct | Dec 15, 2021 (0d) |
| Dec 2, 2021 | CYTH | ↑ Buy | 5,000 | $4.93 | $25K | Direct | Dec 2, 2021 (0d) |
| Nov 19, 2021 | CYTH | ↑ Buy | 5,000 | $5.25 | $26K | Direct | Nov 19, 2021 (0d) |
| Sep 15, 2021 | CYTH | ↑ Buy | 5,000 | $6.35 | $32K | Direct | Sep 15, 2021 (0d) |
| Apr 24, 2020 | CTDH | ↑ Buy | 730,030 | $0.10 | $73K | Direct | Apr 27, 2020 (3d) |
| Sep 18, 2019 | CTDH | ↑ Buy | 10,000 | $0.17 | $2K | Direct | Sep 19, 2019 (1d) |
| Jul 31, 2019 | CTDH | ↑ Buy | 50,000 | $0.25 | $13K | Direct | Jul 31, 2019 (0d) |
| Feb 19, 2014 | CTDH | ↑ Buy | 4,500,000 | $0.05 | $225K | Direct | Feb 21, 2014 (2d) |
| May 11, 2010 | CEDC | ↓ Sell | 7,500 | $29.50 | $221K | Direct | May 13, 2010 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About N Scott Fine's insider trades
N Scott Fine is Chief Executive Officer at Cyclo Therapeutics (CYTH). Since May 11, 2010, N has reported 11 open-market purchases worth $683K and 1 sale worth $221K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (20 filings), other transactions (10 filings), option exercises (3 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CYTH insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.